Cargando…
Oligonucleotides targeting coagulation factor mRNAs: use in thrombosis and hemophilia research and therapy
Small interfering (si) RNAs and antisense oligonucleotides (ASOs; here for simplicity reasons, both referred to as oligonucleotides) are small synthetic RNA or DNA molecules with a sequence complementary to a (pre)mRNA. Although the basic mechanisms of action between siRNAs and ASO are distinct, a s...
Autores principales: | Heestermans, Marco, van Vlijmen, Bart J.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341404/ https://www.ncbi.nlm.nih.gov/pubmed/28286423 http://dx.doi.org/10.1186/s12959-017-0130-8 |
Ejemplares similares
-
Translation can affect the antisense activity of RNase H1-dependent oligonucleotides targeting mRNAs
por: Liang, Xue-Hai, et al.
Publicado: (2018) -
Deep sequencing of circulating miRNAs and target mRNAs level in deep venous thrombosis patients
por: Wang, Qingxian, et al.
Publicado: (2023) -
Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond
por: Krichevsky, Anna M., et al.
Publicado: (2019) -
Role of microRNAs in Hemophilia and Thrombosis in Humans
por: Jankowska, Katarzyna I., et al.
Publicado: (2020) -
Coagulation Factor IX for Hemophilia B Therapy
por: Orlova, N. A., et al.
Publicado: (2012)